Literature DB >> 14516703

Monoclonal antibody-based competitive ELISA for simultaneous detection of rinderpest virus and peste des petits ruminants virus antibodies.

Kang-Seuk Choi1, Jin-Ju Nah, Cheong-Up Choi, Young-Joon Ko, Hyun-Joo Sohn, Genevieve Libeau, Shien-Young Kang, Yi-Seok Joo.   

Abstract

An experimental competitive enzyme-linked immunosorbent assay (morbillivirus cELISA) using a recombinant N antigen (rRPV N) expressed in a baculovirus and a ruminant morbillivirus (RPV and PPRV)-specific monoclonal antibody (P-13A9) was developed for simultaneous detection of rinderpest virus (RPV) and peste des petits ruminants virus (PPRV) antibodies and its diagnostic performance was evaluated. A set of known reference antisera against RPV and PPRV belonging to different lineages, experimental sera from cattle vaccinated for a RPV of Asian lineage, and field sera from cattle and sheep/goat populations known to be positive (West Africa) and negative (Korea) for RPV and PPRV were used for the evaluation. Morbillivirus cELISA results on the panel of experimental RPV and PPRV antisera showed high correlation (r=0.97) between the whole virus and the rRPV N antigens, suggesting that the rRPV N contains a ruminant morbillivirus-specific antigenic determinant recognized by the P-13A9 and it may be suitable as an ELISA antigen in place of the whole virus. Morbillivirus cELISA detected anti-RPV and anti-PPRV antibodies in all reference RPV and PPRV antisera containing VN titers >/=1:8, suggesting that the assay can simultaneously detect antibodies against RPV and PPRV. Anti-RPV antibody was detected by morbillivirus cELISA in vaccinated cattle as early as the VNT and continued to be detectable by both the cELISA and the VNT until termination of the study. When applied to field samples from Africa, morbillivirus cELISA showed good agreement with a RP cELISA kit (kappa value of 0.86) in bovine sera and with a peste des petits ruminant cELISA kit (kappa value of 0.81) in caprine/ovine sera. Usefulness of morbillivirus cELISA using the rRPV N protein was discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14516703     DOI: 10.1016/s0378-1135(03)00201-3

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Rapid competitive enzyme-linked immunosorbent assay for detection of antibodies to peste des petits ruminants virus.

Authors:  Kang-Seuk Choi; Jin-Ju Nah; Young-Joon Ko; Shien-Young Kang; Nam-In Jo
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

2.  Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay.

Authors:  Young-Joon Ko; Kang-Seuk Choi; Jin-Ju Nah; David J Paton; Jae-Ku Oem; Ginette Wilsden; Shien-Young Kang; Nam-In Jo; Joo-Ho Lee; Jae-Hong Kim; Hee-Woo Lee; Jong-Myeong Park
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

3.  Antigenic and immunogenic investigation of B-cell epitopes in the nucleocapsid protein of peste des petits ruminants virus.

Authors:  Kang-Seuk Choi; Jin-Ju Nah; Young-Joon Ko; Shien-Young Kang; Kyoung-Jin Yoon; Nam-In Jo
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

4.  Characterization of immunodominant linear B-cell epitopes on the carboxy terminus of the rinderpest virus nucleocapsid protein.

Authors:  Kang-Seuk Choi; Jin-Ju Nah; Young-Joon Ko; Shien-Young Kang; Kyoung-Jin Yoon; Yi-Seok Joo
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

5.  Development of a helper cell-dependent form of peste des petits ruminants virus: a system for making biosafe antigen.

Authors:  Jana Baron; Michael D Baron
Journal:  Vet Res       Date:  2015-09-23       Impact factor: 3.683

6.  Development of real-time and lateral flow strip reverse transcription recombinase polymerase Amplification assays for rapid detection of peste des petits ruminants virus.

Authors:  Yang Yang; Xiaodong Qin; Yiming Song; Wei Zhang; Gaowei Hu; Yongxi Dou; Yanmin Li; Zhidong Zhang
Journal:  Virol J       Date:  2017-02-07       Impact factor: 4.099

7.  Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR.

Authors:  Muneeswaran Selvaraj; Mana Mahapatra; Satya Parida
Journal:  Viruses       Date:  2021-11-21       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.